Specialty Therapies and Biosimilars Congress

Breakthrough barriers to entry & ensure optimal payer positioning for access
  • Managing the Patient’s Journey — Payer Contracts, Point-of-Care and Formulary
  • Biosimilars Contested Proceedings, Litigation and Patent Law
  • Biosimilar Adoption and Barriers to Success — Current and Future Considerations
Examine the latest cost management and product pricing measures
  • Medicare 2020 Report
  • Drug Pricing and Reimbursement
  • Navigating the Regulatory and Legislative Marketplace Changes
  • Opportunities with Value-Based Contracts
Uncover the latest in novel therapy and biosimilar pipeline innovations
  • A 360º View of Cell and Gene Therapy
  • Specialty Therapies and Biosimilars Pipeline Report
  • The Evolving Patient Journey in Oncology Management

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is:
Specialty Therapies and Biosimilars Congress